Tandem Diabetes Care (TNDM) Stock Analysis: AI Score & Alternative Data
TNDM alt-data: job postings climbing, web traffic lagging
Is Tandem Diabetes Care a buy right now? The alternative data says hold. This TNDM stock analysis is built on the 25+ alternative data signals AltIndex tracks on Tandem Diabetes Care every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 54/100: a Hold. The stock trades at $17.11 with a $1B market cap.
The bullish side of the 90-day ledger: job postings up 43.2% to 53 open roles. The drag: web traffic down 11.0% to 358K monthly visits, just 28% of employees report a positive business outlook, and app downloads down 75.3% to 76 downloads. That tension is what keeps the score mid-range.
TNDM’s broader alt-data profile also covers headcount (2K employees, according to LinkedIn), quarterly revenue ($250M), Facebook followers (83K), and sentiment (100/100). Every signal links to its own page with full history, the TNDM technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on TNDM is just below.
Tandem Diabetes Care AI Stock Analysis
Tandem Diabetes Care, Inc. is a medical device company specializing in the development and commercialization of products for people with diabetes. The company stands out for its innovative insulin pump technology, which aims to improve the quality of life for diabetes patients.
Analysis generated August 31, 2026.
Recent Tandem Diabetes Care Stock Alerts
|
Tandem Diabetes Care | September 11 Price is down by -6.2% in the last 24h. |
|
Tandem Diabetes Care | August 31 Employee Rating is down by 3.1% over the last month. |
|
Tandem Diabetes Care | August 18 Price is up by 6.5% in the last 24h. |
|
Tandem Diabetes Care | August 8 Business Outlook among employees is up by 4% over the last month. |
Tandem Diabetes Care Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 358K | 11.0% | |
| App Downloads | 76 | 75.3% | |
| Job Posts | 53 | 43.2% | |
| LinkedIn Employees | 2K | 0% | |
| Wikipedia Views | 27 | 50.0% | |
| Employee Recommend | 41 | 0% | |
| Business Outlook | 28 | 3.7% | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 4 | 60.0% | |
| Stocktwits Mentions | 4 | 63.6% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 14K | 0% | |
| 4chan Mentions | 0 | N/A | |
| X Followers | 12K | 0% | |
| Instagram Followers | 57K | 3.5% | |
| Facebook Followers | 83K | 0.7% | |
| Facebook Engagement | 589 | 96.3% |
About Tandem Diabetes Care (TNDM)
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
| Price | $17.11 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $1B |
| Year Range | $12 – $28 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Medical Devices |
Latest Tandem Diabetes Care News
View more →
Tandem Diabetes Care (TNDM) Slid as Lower Beta Profile Lags in Risk On MarketJuly 30 - Yahoo Entertainment |
|
 |
Is the Market Underestimating Tandem Diabetes Care, Inc. (TNDM)’s Transition Risks?July 6 - Biztoc.com |
 |
Insulin Pump Correction: Tandem Diabetes Care Issues Correction for Tandem Mobi Insulin PumpsApril 21 - FDA.gov |
Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and YpsomedApril 21 - GlobeNewswire |
|
Tandem Diabetes Care, Inc. Investigated by the Portnoy Law FirmMarch 27 - GlobeNewswire |
See Tandem Diabetes Care’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for TNDM, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREETandem Diabetes Care Earnings & Financial Performance
View all earnings →Tandem Diabetes Care Insider Trading Activity
View all →| Novara Mark David filed to sell 37,656 shares at $0.0. Mar 17 '26 |
| Novara Mark David filed to sell 35,969 shares at $0.0. Mar 5 '26 |
| Sheridan John F filed to sell 106,327 shares at $0.0. Aug 11 '25 |
| Vosseller Leigh filed to sell 25,580 shares at $0.0. Aug 8 '25 |
| Kyrillos Jean-Claude filed to sell 10,538 shares at $0.0. Mar 7 '25 |
Tandem Diabetes Care Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Oct 16, 25 | Buy | $8K+ |
| Josh Gottheimer |
Apr 11, 25 | Sell | $8K+ |
| Gil Cisneros |
Apr 8, 25 | Buy | $8K+ |
| Josh Gottheimer |
Sep 11, 24 | Buy | $8K+ |
| Daniel S. Goldman |
Aug 13, 23 | Sell | $8K+ |
Stocks Similar to Tandem Diabetes Care
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Integra LifesciencesIART |
$15.50 0.3% | $1B | 44 |
 |
Avanos MedicalAVNS |
$24.99 0.0% | $1B | 49 |
 |
PROCEPT BioRoboticsPRCT |
$20.38 1.5% | $1B | 48 |
 |
ArtivionAORT |
$25.08 1.7% | $1B | 54 |
 |
ConmedCNMD |
$46.30 0.2% | $1B | 54 |
Explore Tandem Diabetes Care Data
Frequently Asked Questions: Tandem Diabetes Care (TNDM)
Tandem Diabetes Care has an AltIndex AI Score of 54/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
54/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Tandem Diabetes Care (TNDM) stock is $17.11 with a market cap of $1B.
As of today, Tandem Diabetes Care’s PE (Price to Earnings) ratio is —.
View the latest Tandem Diabetes Care insider transactions to see recent buying and selling activity by company executives and directors.
Check the Tandem Diabetes Care congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The TNDM stock price chart above shows Tandem Diabetes Care’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Tandem Diabetes Care technical analysis for RSI, moving averages, and more.
See the stocks similar to Tandem Diabetes Care section on this page for companies in the same industry ranked by market cap and AI Score.
